Firefighter Files Lawsuit Over Kidney Cancer, Prostate Cancer Diagnosis Caused By AFFF Foam

A Florida firefighter indicates he developed kidney and prostate cancer after being regularly exposed to aqueous film-forming foams (AFFFs) used to fight fires, which contained toxic chemicals known to build up in the body and cause several health risks.

The complaint (PDF) was filed by Joseph Attanasio in the U.S. District Court for the District of South Carolina on on July 1, naming dozens of safety equipment and chemical manufacturers as defendants, indicating they all contributed to the use, spread, exposure and lack of warning regarding the presence of per- and polyfluoroalkyl substances (PFAS) in firefighter foams.

Attanasio indicates he regularly used the toxic AFFF foam both while fighting fires, and during firefighter training exercises, alleging he was never warned to take extra precautions against exposure.

AFFF Cancer Lawsuit
AFFF Cancer Lawsuit

“The Plaintiff was never informed that this product was inherently dangerous,” the lawsuit states. “Nor was the Plaintiff warned about the known health risks associated with this product.”

According to the lawsuit, Attanasio was never given adequate protective gear to prevent exposure to the PFAS chemicals in the firefighter foam, ultimately resulting in a kidney cancer and prostate cancer diagnosis.

PFAS were first introduced into the manufacturing industry in the 1940’s, because of their ability to resist heat, grease, stains, and water. However, since then the chemicals have been linked to a myriad of adverse health effects including liver damage, thyroid disease, decreased fertility, high cholesterol, obesity, hormone suppression, and cancer.

Experts indicate PFAS chemicals contained in the firefighter foam can take thousands of years to degrade, and past studies have highlighted their ability to enter and stay in the environment and human body through the air, dust, food, soil, and water.

Attanasio’s complaint joins a growing number of AFFF foam cancer lawsuits filed nationwide by former service members, civilian firefighters and residents living near military bases or chemical plants, all involving claims that cancer and other ailments were caused by exposure to PFAS from the firefighter foam.

Given common questions of fact and law raised in the cases, the federal litigation is centralized in the U.S. District Court for the District of South Carolina, where it is expected that a small group of “bellwether” cases will be prepared for early trial dates, to help the parties gauge how juries respond to certain evidence and testimony that will be repeated throughout the claims. However, if settlements or another resolution for the lawsuits is not reached following coordinated pretrial proceedings, hundreds of individual claims brought by firefighters and others may later be remanded to U.S. District Courts nationwide for separate jury trials.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.
Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.